XML 46 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Cash Flows from Operating Activities:    
Net (loss) $ (5,944,797) $ (5,757,648)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:    
Income from discontinued operations 3,287,258 741,685
Depreciation and amortization 475,857 570,650
Goodwill Impairment 0 905,810
Loss on disposal of assets 86,885 0
Compensation expense related to stock options 73,353 111,054
Change in accrued post-retirement benefits 56,150 (41,719)
Loss of Ocular Telehealth Management, LLC (7,491) 70,393
Change in operating assets and liabilities:    
Accounts receivable, net 835,242 (254,870)
Inventory, net 1,239,881 604,892
Other current and long-term assets (160,974) 411,514
Accounts payable and accrued expenses (368,700) 709,158
Net cash (used in) operating activities from continuing operations (427,336) (1,929,081)
Net cash (used in) provided by operating activities from discontinued operations (273,234) 1,414,145
Net cash (used in) operating activities (700,570) (514,936)
Cash Flows from Investing Activities:    
Investment in Ocular Telehealth Management, LLC 0 (45,000)
Purchase of fixed assets (79,155) (252,340)
Net cash (used in) investing activities from continuing operations (79,155) (297,340)
Net cash (used in) investing activities from discontinued operations including proceeds from sale of vascular assets 0 (104,949)
Net cash (used in) investing activities (79,155) (402,289)
Cash Flows from Financing Activities:    
Proceeds from related party note payable 300,000 0
Principal payments on long-term debt (155,795) (122,732)
Net cash used in financing activities from continuing operations 144,205 (122,732)
Effect of exchange rate changes on cash and cash equivalents 11,629 (269,732)
Net (decrease) increase in cash and cash equivalents (623,891) (1,309,689)
Cash and cash equivalents, beginning of period 1,514,514 2,824,203
Cash and cash equivalents, end of period 890,623 1,514,514
Supplemental Schedule of Cash Flow Information:    
Interest paid $ 170,550 $ 323,611